Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"RNA, U6 small nuclear 711, pseudogene" (RNU6-711P) designates a pseudogene sequence in the human genome that is homologous to the functional U6 small nuclear RNA gene. U6 snRNA is a critical component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[1][3]. However, as a pseudogene, RNU6-711P lacks the capacity to encode a functional RNA due to disabling mutations or truncations. Such U6 pseudogenes commonly arise through retrotransposition and are distributed extensively in the genome, where they serve as genomic "fossils" rather than actively participating in biology[7][8]. They may be useful markers for studying retrotransposition events but have no known biological function and are not therapeutic targets.\n\nClarifications on interpretation:\n- "RNU6-711P" is a pseudogene, not an active receptor, enzyme, or other molecular target, nor is it implicated in drug targeting, biological functions, or disease mechanisms[8][7].\n- Functional, canonical U6 snRNA (encoded by, e.g., RNU6-1) is essential for the spliceosome, while pseudogene copies do not contribute to splicing or gene regulation[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 711, pseudogene (RNU6-711P).